stockportfolio.pro
Stocks / ELAN vs PODD
ELAN vs PODD
Elanco Animal Health Incorporated and Insulet Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Elanco Animal Health Incorporated (ELAN) | Insulet Corporation (PODD) | |
|---|---|---|
| Market cap | $11.5B | $11.1B |
| Revenue (latest FY) | $4.71B | $2.71B |
| Net income (latest FY) | $-232.00M | $247.10M |
| Revenue growth (5y CAGR) | 7.6% | 24.5% |
| Net margin | -4.9% | 9.1% |
| Return on equity | -3.5% | 16.3% |
| P/E ratio | — | 37.4 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 3 | 8 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ELAN — free Open PODD — freeFrequently asked questions
Which is bigger, ELAN or PODD?
Elanco Animal Health Incorporated is larger by market capitalization — $11.5B versus $11.1B.
Which grows faster, ELAN or PODD?
Over the last five fiscal years, Insulet Corporation grew revenue faster — 24.5%/yr versus 7.6%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.